• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

研究对照肿瘤和化疗治疗肿瘤的纵向血管变化,以作为治疗效果预测指标。

Investigation of longitudinal vascular changes in control and chemotherapy-treated tumors to serve as therapeutic efficacy predictors.

作者信息

Su M Y, Wang Z, Nalcioglu O

机构信息

Health Sciences Research Imaging Center, College of Medicine, University of California, Irvine 92697-5020, USA.

出版信息

J Magn Reson Imaging. 1999 Jan;9(1):128-37. doi: 10.1002/(sici)1522-2586(199901)9:1<128::aid-jmri17>3.0.co;2-e.

DOI:10.1002/(sici)1522-2586(199901)9:1<128::aid-jmri17>3.0.co;2-e
PMID:10030660
Abstract

The impact of chemotherapy on longitudinal vascular changes taking place during the growth of an animal tumor, R3230 AC adenocarcinoma, was investigated. Two contrast agents of different molecular weights, gadolinium-diethylene-triamine-pentaacetic acid (Gd-DTPA; < 1 kD) and gadomer-17 (35 kD), were used in the dynamic imaging studies. Enhancement kinetics were analyzed by a pharmacokinetic model to derive parameters related to vascular volume and permeability on a pixel-by-pixel basis. Responders and non-responders were separated according to tumor size 10 days after the therapy. Changes in the vascular volume measured by gadomer-17 at 4 days after therapy revealed a clear distinction between the controls and the responders/non-responders. Mean vascular volume decreased by 42% in responders but was not significantly changed in the controls. The one non-responder had increased vascular volume after chemotherapy. Enhancement kinetics of gadomer-17 detected the changes earlier and with greater sensitivity than Gd-DTPA. In the control group, vascular permeability determined by gadomer-17 correlated with the longitudinal growth rates of tumors, suggesting that vascular permeability assessed by gadomer-17 could potentially serve as an indicator of aggressive tumor growth.

摘要

研究了化疗对动物肿瘤R3230 AC腺癌生长过程中纵向血管变化的影响。在动态成像研究中使用了两种不同分子量的造影剂,钆-二乙烯三胺五乙酸(Gd-DTPA;<1 kD)和钆聚合物-17(35 kD)。通过药代动力学模型分析增强动力学,以逐像素得出与血管体积和通透性相关的参数。根据治疗后10天的肿瘤大小将反应者和无反应者分开。治疗后4天用钆聚合物-17测量的血管体积变化显示,对照组与反应者/无反应者之间有明显区别。反应者的平均血管体积减少了42%,但对照组无明显变化。一名无反应者化疗后血管体积增加。钆聚合物-17的增强动力学比Gd-DTPA更早且更灵敏地检测到这些变化。在对照组中,钆聚合物-17测定的血管通透性与肿瘤的纵向生长速率相关,这表明钆聚合物-17评估的血管通透性可能作为侵袭性肿瘤生长的一个指标。

相似文献

1
Investigation of longitudinal vascular changes in control and chemotherapy-treated tumors to serve as therapeutic efficacy predictors.研究对照肿瘤和化疗治疗肿瘤的纵向血管变化,以作为治疗效果预测指标。
J Magn Reson Imaging. 1999 Jan;9(1):128-37. doi: 10.1002/(sici)1522-2586(199901)9:1<128::aid-jmri17>3.0.co;2-e.
2
A longitudinal study of radiation-induced changes in tumor vasculature by contrast-enhanced magnetic resonance imaging.
Radiat Res. 2002 Aug;158(2):152-8. doi: 10.1667/0033-7587(2002)158[0152:alsori]2.0.co;2.
3
Measurement of volumetric and vascular changes with dynamic contrast enhanced MRI for cancer therapy monitoring.利用动态对比增强磁共振成像测量体积和血管变化以监测癌症治疗。
Technol Cancer Res Treat. 2002 Dec;1(6):479-88. doi: 10.1177/153303460200100608.
4
Tumor characterization with dynamic contrast-enhanced MRI using MR contrast agents of various molecular weights.使用不同分子量的磁共振造影剂通过动态对比增强磁共振成像进行肿瘤特征描述。
Magn Reson Med. 1998 Feb;39(2):259-69. doi: 10.1002/mrm.1910390213.
5
Quantifying angiogenesis in VEGF-enhanced tissue-engineered bladder constructs by dynamic contrast-enhanced MRI using contrast agents of different molecular weights.使用不同分子量的造影剂,通过动态对比增强磁共振成像对VEGF增强的组织工程膀胱构建体中的血管生成进行定量分析。
J Magn Reson Imaging. 2007 Jan;25(1):137-45. doi: 10.1002/jmri.20787.
6
Simultaneous MRI measurement of blood flow, blood volume, and capillary permeability in mammary tumors using two different contrast agents.
J Magn Reson Imaging. 2000 Dec;12(6):991-1003. doi: 10.1002/1522-2586(200012)12:6<991::aid-jmri26>3.0.co;2-1.
7
Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after X-irradiation.X线照射后实验性乳腺癌毛细血管通透性改变的对比增强磁共振成像评估
Invest Radiol. 1994 Nov;29(11):970-7. doi: 10.1097/00004424-199411000-00004.
8
In vivo imaging of extraction fraction of low molecular weight MR contrast agents and perfusion rate in rodent tumors.啮齿类动物肿瘤中低分子量磁共振造影剂提取分数及灌注率的体内成像
Magn Reson Med. 1997 Aug;38(2):259-68. doi: 10.1002/mrm.1910380215.
9
Pathological animal models in the experimental evaluation of tumour microvasculature with magnetic resonance imaging.用于磁共振成像评估肿瘤微血管的病理动物模型。
Radiol Med. 2007 Apr;112(3):319-28. doi: 10.1007/s11547-007-0144-6. Epub 2007 Apr 20.
10
Pharmacokinetic changes induced by vasomodulators in kidneys, livers, muscles, and implanted tumors in rats as measured by dynamic Gd-DTPA-enhanced MRI.通过动态钆喷酸葡胺增强磁共振成像测量血管调节剂对大鼠肾脏、肝脏、肌肉和植入肿瘤的药代动力学变化。
Magn Reson Med. 1996 Dec;36(6):868-77. doi: 10.1002/mrm.1910360609.

引用本文的文献

1
Impact of drug size on brain tumor and brain parenchyma delivery after a blood-brain barrier disruption.药物粒径对血脑屏障破坏后脑肿瘤和脑实质递送的影响。
J Cereb Blood Flow Metab. 2014 May;34(5):820-6. doi: 10.1038/jcbfm.2014.14. Epub 2014 Feb 12.
2
MRI methods for evaluating the effects of tyrosine kinase inhibitor administration used to enhance chemotherapy efficiency in a breast tumor xenograft model.用于评估酪氨酸激酶抑制剂给药效果的MRI方法,该抑制剂用于增强乳腺肿瘤异种移植模型中的化疗效率。
J Magn Reson Imaging. 2009 May;29(5):1071-9. doi: 10.1002/jmri.21737.
3
Applications of magnetic resonance in model systems: cancer therapeutics.
磁共振在模型系统中的应用:癌症治疗学
Neoplasia. 2000 Jan-Apr;2(1-2):152-65. doi: 10.1038/sj.neo.7900078.